Evidence map›Paper›PMID 24043878›Full record

ArticleSchizophrenia bulletin2014

Common variants on Xq28 conferring risk of schizophrenia in Han Chinese.

Emily H M Wong, Hon-Cheong So, Miaoxin Li, Quang Wang, Amy W Butler, Basil Paul, Hei-Man Wu, Tomy C K Hui, Siu-Chung Choi, Man-Ting So and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 4 countries.

Emily H M WongDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; Co-first authors.
Hon-Cheong SoDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; Co-first authors.
Miaoxin LiDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; Centre for Genomic Sciences, The University of Hong Kong, Hong Kong, China;
Quang WangThe Mental Health Centre and Psychiatric Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China;
Amy W ButlerDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK;
Basil PaulDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Hei-Man WuDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Tomy C K HuiDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Siu-Chung ChoiDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Man-Ting SoDepartment of Surgery, The University of Hong Kong, Hong Kong, China;
Maria-Mercè Garcia-BarceloCentre for Genomic Sciences, The University of Hong Kong, Hong Kong, China; Department of Surgery, The University of Hong Kong, Hong Kong, China;
Grainne M McAlonanDepartment of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, King's College London, UK;
Eric Y H ChenDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Eric F C CheungCastle Peak Hospital, Hong Kong, China;
Raymond C K ChanInstitute of Psychology, Chinese Academy of Sciences, Beijing, China;
Shaun M PurcellDivision of Psychiatric Genomics, Mount Sinai School of Medicine, New York;
Stacey S ChernyDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; Centre for Genomic Sciences, The University of Hong Kong, Hong Kong, China; State Key Laboratory in Brain and Cognitive Sciences, The University of Hong Kong, Hong King, China;
Ronald R L ChenDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China;
Tao LiThe Mental Health Centre and Psychiatric Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China;
Pak-Chung ShamDepartment of Psychiatry, The University of Hong Kong, Hong Kong, China; Centre for Genomic Sciences, The University of Hong Kong, Hong Kong, China; State Key Laboratory in Brain and Cognitive Sciences, The University of Hong Kong, Hong King, China; pcsham@hku.hk.
University of Hong Kong · HKChinese University of Hong Kong · CNHealth First · USCastle Peak Hospital · CNIcahn School of Medicine at Mount Sinai · USInstitute of Psychology, Chinese Academy of Sciences · CNKing's College London · GBPsychiatry Research Trust · GBSichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a highly heritable, severe psychiatric disorder affecting approximately 1% of the world population. A substantial portion of heritability is still unexplained and the pathophysiology of schizophrenia remains to be elucidated. To identify more schizophrenia susceptibility loci, we performed a genome-wide association study (GWAS) on 498 patients with schizophrenia and 2025 controls from the Han Chinese population, and a follow-up study on 1027 cases and 1005 controls. In the follow-up study, we included 384 single nucleotide polymorphisms (SNPs) which were selected from the top hits in our GWAS (130 SNPs) and from previously implicated loci for schizophrenia based on the SZGene database, NHGRI GWAS Catalog, copy number variation studies, GWAS meta-analysis results from the international Psychiatric Genomics Consortium (PGC) and candidate genes from plausible biological pathways (254 SNPs). Within the chromosomal region Xq28, SNP rs2269372 in RENBP achieved genome-wide significance with a combined P value of 3.98 × 10(-8) (OR of allele A = 1.31). SNPs with suggestive P values were identified within 2 genes that have been previously implicated in schizophrenia, MECP2 (rs2734647, P combined = 8.78 × 10(-7), OR = 1.28; rs2239464, P combined = 6.71 × 10(-6), OR = 1.26) and ARHGAP4 (rs2269368, P combined = 4.74 × 10(-7), OR = 1.25). In addition, the patient sample in our follow-up study showed a significantly greater burden for pre-defined risk alleles based on the SNPs selected than the controls. This indicates the existence of schizophrenia susceptibility loci among the SNPs we selected. This also further supports multigenic inheritance in schizophrenia. Our findings identified a new schizophrenia susceptibility locus on Xq28, which harbor the genes RENBP, MECP2, and ARHGAP4.

Indexed as

AllelesAsian PeopleCarbohydrate EpimerasesCarrier ProteinsCase-Control StudiesChinaChromosomes, Human, XFemaleGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyGTPase-Activating ProteinsHumansLogistic ModelsMaleMethyl-CpG-Binding Protein 2ARHGAP4 protein, humanCarbohydrate EpimerasesCarrier ProteinsGTPase-Activating ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2RENBP protein, humanARHGAP4genome-wide association studyHan ChineseMECP2RENBPschizophrenia

Identifiers

PMID24043878
PMCPMC4059435
OpenAlexW2161757240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.